Table 2.
Comparison of Significance (p value) Between Androgen, Estrogen and Cortisol Levels and Days per Month of Period Pain (DPeriodPM) According to Day of Testing (Days 1–2 or Days 7–10 of Menstrual Cycle) and OC Use (No OC, OC, or Combined) Describing Significance (p value) and Spearman Coefficient (r Value)
| Days 1–2 | Days 7–10 | |||||
|---|---|---|---|---|---|---|
| No OC | OC | Combined | No OC | OC | Combined | |
| DPeriodPM | ||||||
| Testosterone | 0.24 | 0.13 | 0.072 | 0.85 | 0.44 | 0.61 |
| Androstenedione | 0.035* | 0.65 | 0.077 | 0.45 | 0.87 | 0.62 |
| DHEA | 0.013* | 0.81 | 0.060* | 0.33 | 0.96 | 0.53 |
| Free Androgen Index (FAI) | 0.013* | 0.19 | 0.013* | 0.029* | 0.79 | 0.25 |
| Estradiol (E2) | 0.37 | 0.73 | 0.34 | 0.20 | 0.23 | 0.17 |
| Free Estrogen Index (FEI) | 0.98 | 0.54 | 0.84 | 0.74 | 0.099 | 0.75 |
| Cortisol | 0.72 | 0.24 | 0.68 | 0.63 | 0.66 | 0.79 |
Notes: *p ≤ 0.05.